Investor Sentiment Investor Behavior Stock Performance Stock Market Tech Industry Cryptocurrency Consumer Behavior Volatility Investor Relations Economic Indicators
Pending Hart-Scott-Rodino approval, AbbVie will integrate Capstan’s Phase 1 CAR-T candidate with its targeted lipid nanoparticle platform for precise RNA delivery.